EKSO Q2 2021 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M-2.3% YoY

Gross Profit

$1M58.4% margin

Operating Income

-$3M-151.4% margin

Net Income

-$1M-57.6% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+15.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$574,000

Balance Sheet

Total Assets

$53M

Total Liabilities

$13M

Stockholders' Equity

$40M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-2.3%
Gross Profit	$1M	$1M	+2.6%
Operating Income	-$3M	-$3M	-8.3%
Net Income	-$1M	-$12M	+89.2%

Revenue Segments

EksoHealth

$2M84%

EksoWorks

$349,00016%

Geographic Segments

Americas

$1M28%

UNITED STATES

$1M27%

EMEA

$939,00022%

EMEA, Other

$548,00013%

BELGIUM

$296,0007%

GERMANY

$95,0002%

Asia Pacific

$74,0002%

Americas, Other

$44,0001%